[ÀÓ»óÀÇÇÐ ¿¬±¸µ¿Çâ] 2020³â 9¿ù Å°¿öµå ¿¬±¸µ¿Çâ TF-IDF ³×Æ®¿öÅ©ºÐ¼®
ÀÓ»óÀÇÇкоßÀÇ ¿¬±¸µ¿Ç⠺м®À» À§ÇÏ¿© Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbaset)¿¡¼ ÃßÃâµÈ ³í¹®ÀڷḦ ¹ÙÅÁÀ¸·Î Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ 2020³â 9¿ù¿¡ ¹ßÇ¥ÇÑ ±¹³» Àú³Î ³í¹®°ú ¹Ì±¹ ±¹¸³º¸°Ç¿ø PubMed DB¿¡ À妽ºµÈ ±¹¿Ü Àú³Î¿¡ ¹ßÇ¥µÈ ³í¹®À» ºÐ¼®´ë»óÀ¸·Î ÇÏ¿´À½. ÀÓ»óÀÇÇÐºÐ¾ß Å°¿öµå »óÀ§ µ¿ÇâÀº Risk, Women, General Surgery, Neoplasms, Survival Rate, Mortality, Pain, Sensitivity & Specificity, Pediatrics, Complication, Population, Adult, Genes, Recurrence, Role, Stroke, F-18 Fdg Pet, COVID-19, Drug µîÀ¸·Î ³ªÅ¸³².
±×¸² 1. ÀÓ»óÀÇÇÐ 9¿ù ¿¬±¸µ¿Çâ: Å°¿öµå Ŭ¶ó¿ìµå ºÐ¼®
Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ ±¹³»¿Í ±¹¿Ü Àú³Î¿¡ ¹ßÇ¥ÇÑ 2020³â 9¿ù ÀÇ°úÇкоßÀÇ ³í¹® Áß¿¡¼ ÀÓ»óÀÇÇкоßÀÇ ³í¹®Àº ±¹³» Àú³Î¹ßÇ¥ 834Æí, ±¹¿Ü Àú³Î¹ßÇ¥(PubMed À妽º±âÁØ) 1,286ÆíÀ¸·Î ÃÑ 2,110ÆíÀ¸·Î ³ªÅ¸³². ÀÌ´Â Àü¿ù ÀÓ»óÀÇÇÐºÐ¾ß 2094Æí°ú ºñ±³ÇÏ¸é ºñ½ÁÇÑ Ãß¼¼·Î ³ªÅ¸³µÀ½. 9¿ù ¹ßÇ¥µÈ ÀÇ°úÇÐºÐ¾ß Àüü ³í¹® 4,296Æí Áß¿¡¼ ÀÓ»óÀÇÇÐºÐ¾ß ³í¹®ÀÌ Â÷ÁöÇÏ´Â ºñÀ²Àº 49.1%%¸¦ Â÷ÁöÇÏ¿© °¡Àå ³ôÀº ºñÁßÀ» ³ªÅ¸³¿.
±×¸² 2. ÀÓ»óÀÇÇÐºÐ¾ß 9¿ù ¿¬±¸µ¿Çâ ÁÖ¿äÅäÇÈ°ú Å°¿öµå ³×Æ®¿öÅ©
Ç¥ 1. ÀÓ»óÀÇÇÐ : 9¿ù ÅäÇÈ ¸ðµ¨¸µ ÃßÃâ ¿¬±¸µ¿Çâ Å°¿öµå
Topic1
|
Topic2
|
Topic3
|
Topic4
|
Topic5
|
COVID-19
|
Sensitivity & Specificity
|
Neoplasms
|
Mortality
|
Pediatrics
|
Genes
|
Pain
|
Survival Rate
|
Risk
|
Women
|
Role
|
Brain
|
Drug Therapy
|
Complication
|
Adult
|
Humans
|
General Surgery
|
F-18 Fdg Pet
|
General Surgery
|
Risk
|
Pediatrics
|
Hip
|
Exercise
|
Recurrence
|
Depression
|
Neoplasms
|
Women
|
Liver
|
Stroke
|
Bmi
|
Infant
|
Evaluation Studies As Topic
|
Recurrence
|
Survival Rate
|
Sex
|
Economics
|
Complication
|
General Surgery
|
Death
|
Older Adults
|
Asthma
|
Ankle
|
Thorax
|
Emergency Medical Service
|
Diabetes
|
Anti-Bacterial Agents
|
Exercise
|
Breast Neoplasms
|
Population
|
Family
|
9¿ù ÀÓ»óÀÇÇкоßÀÇ ±¹³», ±¹¿Ü ¹ßÇ¥µÈ ¿¬±¸µ¿ÇâºÐ¼® ÅäÇÈ ¸ðµ¨¸µ ÃßÃâ °á°ú´Â Sensitivity and Specificity, Pain, Survival Rate, Mortality, Risk µîÀÇ ÅäÇÈÀ» Áß½ÉÀ¸·Î ¿¬±¸°¡ ÁøÇàµÇ¾úÀ¸¸ç, COVID-19, »ýÁ¸·ü, »ç¸Á·ü ¹× ÅëÁõ µîÀº ÀÓ»óÀÇÇÐºÐ¾ß ÁÖ¿ä ¿¬±¸°³³äÀ¸·Î ³ªÅ¸³². COVID-19¿¡ ´ëÇÑ ¿¬±¸´Â ÀÓ»óÀÇÇко߿¡¼ Áö¼ÓÀûÀÎ ¿¬±¸ÁÖÁ¦·Î ³ªÅ¸³ª°í ÀÖÀ½.
Ç¥ 2. 2020³â 9¿ù ÀÓ»óÀÇÇÐºÐ¾ß TF-IDF(´Ü¾î°¡ÁßÄ¡) ÅäÇÈ Å°¿öµåµ¿Ç⠺м®(N=2,110)
Å°¿öµå ¼øÀ§
|
±¹³»Àú³Î
ÀÓ»óÀÇÇÐ
|
±¹¿ÜÀú³Î
ÀÓ»óÀÇÇÐ
|
ÀÓ»óÀÇÇÐ
¿¬±¸µ¿Çâ Å°¿öµå
|
1
|
Risk
|
Risk
|
Risk
|
2
|
Women
|
Neoplasms
|
Women
|
3
|
General Surgery
|
Survival Rate
|
General Surgery
|
4
|
Pain
|
General Surgery
|
Neoplasms
|
5
|
Pediatrics
|
Women
|
Survival Rate
|
6
|
Exercise
|
Sensitivity And Specificity
|
Mortality
|
7
|
Complication
|
Mortality
|
Pain
|
8
|
COVID-19
|
Population
|
Sensitivity And Specificity
|
9
|
Mortality
|
Recurrence
|
Pediatrics
|
10
|
Balance
|
Genes
|
Complication
|
11
|
Adult
|
Pain
|
Population
|
12
|
Neoplasms
|
Pediatrics
|
Adult
|
13
|
Drug
|
F-18 Fdg Pet
|
Genes
|
14
|
Sensitivity And Specificity
|
Adult
|
Recurrence
|
15
|
Older Adults
|
Stroke
|
Role
|
16
|
Humans
|
Role
|
Stroke
|
17
|
Bmi
|
Death
|
F-18 Fdg Pet
|
18
|
Population
|
Complication
|
COVID-19
|
19
|
Role
|
Brain
|
Drug
|
20
|
Drug Therapy
|
Drug Therapy
|
Exercise
|
ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedRIC) Á¦°ø